1.
              Smadja DM, Gaussem P, Mauge L, Israel-Biet D, Dignat-George F, et al. (2009) Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation 119: 374381.
        doi:
        10.1161/CIRCULATIONAHA.108.808246.
       
                      Find this article online
                    
2.
              Woywodt A, Blann AD, Kirsch T, Erdbruegger U, Banzet N, et al. (2006) Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. J Thromb Haemost 4: 671677.
        doi:
        10.1111/j.1538-7836.2006.01794.x.
       
                      Find this article online
                    
3.
              DuBois SG, Stempak D, Wu B, Mokhtari RB, Nayar R, et al. (2012) Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma. Pediatr Blood Cancer 58: 181184.
        doi:
        10.1002/pbc.23046.
       
                      Find this article online
                    
4.
              Damani S, Bacconi A, Libiger O, Chourasia AH, Serry R, et al. (2012) Characterization of circulating endothelial cells in acute myocardial infarction. Sci Transl Med 4: 126ra133.
        doi:
        10.1126/scitranslmed.3003451.
       
                      Find this article online
                    
5.
              Kondo S, Ueno H, Hashimoto J, Morizane C, Koizumi F, et al. (2012) Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy. BMC Cancer 12: 268.
        doi:
        10.1186/1471-2407-12-268.
       
                      Find this article online
                    
6.
              Ring A, Smith IE, Dowsett M (2004) Circulating tumour cells in breast cancer. Lancet Oncol 5: 7988.
        doi:
        10.1016/S1470-2045(04)01381-6.
       
                      Find this article online
                    
7.
              Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964967.
        doi:
        10.1126/science.275.5302.964.
       
                      Find this article online
                    
8.
              Shaked Y, Kerbel RS (2007) Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy. Cancer Res 67: 70557058.
        doi:
        10.1158/0008-5472.CAN-07-0905.
       
                      Find this article online
                    
9.
              Nanda A, Karim B, Peng Z, Liu G, Qiu W, et al. (2006) Tumor endothelial marker 1 (Tem1) functions in the growth and progression of abdominal tumors. Proc Natl Acad Sci U S A 103: 33513356.
        doi:
        10.1073/pnas.0511306103.
       
                      Find this article online
                    
10.
              Bertolini F, Paul S, Mancuso P, Monestiroli S, Gobbi A, et al. (2003) Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Cancer Res 63: 43424346. 
                      Find this article online
                    
11.
              Malyszko J, Malyszko JS, Brzosko S, Wolczynski S, Mysliwiec M (2004) Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab 89: 46204627.
        doi:
        10.1210/jc.2004-0387.
       
                      Find this article online
                    
12.
              Elshal MF, Khan SS, Takahashi Y, Solomon MA, McCoy JP (2005) CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 106: 29232924.
        doi:
        10.1182/blood-2005-06-2307.
       
                      Find this article online
                    
13.
              Mancuso P, Calleri A, Cassi C, Gobbi A, Capillo M, et al. (2003) Circulating endothelial cells as a novel marker of angiogenesis. Adv Exp Med Biol 522: 8397. 
                      Find this article online
                    
14.
              Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, et al. (2003) Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 102: 26782683.
        doi:
        10.1182/blood-2003-03-0693.
       
                      Find this article online
                    
15.
              St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, et al. (2000) Genes expressed in human tumor endothelium. Science 289: 11971202.
        doi:
        10.1126/science.289.5482.1197.
       
                      Find this article online
                    
16.
              Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438: 932936.
        doi:
        10.1038/nature04478.
       
                      Find this article online
                    
17.
              Beaudry P, Force J, Naumov GN, Wang A, Baker CH, et al. (2005) Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity. Clin Cancer Res 11: 35143522.
        doi:
        10.1158/1078-0432.CCR-04-2271.
       
                      Find this article online
                    
18.
              Bertolini F, Shaked Y, Mancuso P, Kerbel RS (2006) The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 6: 835845.
        doi:
        10.1038/nrc1971.
       
                      Find this article online
                    
19.
              Yao Y, Wang L, Zhang H, Wang H, Zhao X, et al. (2012) A Novel Anticancer Therapy That Simultaneously Targets Aberrant p53 and Notch Activities in Tumors. PLoS One 7: e46627.
        doi:
        10.1371/journal.pone.0046627.
       
                      Find this article online
                    
20.
              Doroszewski W, Wlodarczyk Z, Strozecki P, Manitius J, Grabarczyk E, et al. (2007) [Assessment of plasminogen activator inhibitor-1 and von Willebrand factor as a markers of endothelial function in patients with end-stage kidney disease after allotransplantation during a one-year follow-up]. Pol Arch Med Wewn 117: 213220. 
                      Find this article online
                    
21.
              Rodriguez-Osorio X, Sobrino T, Brea D, Martinez F, Castillo J, et al. (2012) Endothelial progenitor cells: a new key for endothelial dysfunction in migraine. Neurology 79: 474479.
        doi:
        10.1212/WNL.0b013e31826170ce.
       
                      Find this article online
                    
22.
              De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, et al. (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8: 211226.
        doi:
        10.1016/j.ccr.2005.08.002.
       
                      Find this article online
                    
23.
              Sun X, Cheng L, Duan H, Lin G, Lu G (2012) Characterization and comparison of embryonic stem cell-derived KDR+ cells with endothelial cells. Microvasc Res 84: 149154.
        doi:
        10.1016/j.mvr.2012.06.003.
       
                      Find this article online
                    
24.
              Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, et al. (2001) Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 97: 36583661.
        doi:
        10.1182/blood.V97.11.3658.
       
                      Find this article online
                    
25.
              Rowand JL, Martin G, Doyle GV, Miller MC, Pierce MS, et al. (2007) Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry A 71: 105113.
        doi:
        10.1002/cyto.a.20364.
       
                      Find this article online
                    
26.
              Beerepoot LV, Mehra N, Vermaat JS, Zonnenberg BA, Gebbink MF, et al. (2004) Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 15: 139145.
        doi:
        10.1093/annonc/mdh017.
       
                      Find this article online
                    
27.
              Calleri A, Bono A, Bagnardi V, Quarna J, Mancuso P, et al. (2009) Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab. Clin Cancer Res 15: 76527657.
        doi:
        10.1158/1078-0432.CCR-09-1493.
       
                      Find this article online
                    
28.
              Fleitas T, Martinez-Sales V, Vila V, Reganon E, Mesado D, et al. (2012) Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer. PLoS One 7: e47365. 
                      Find this article online
                    